# HCWB (HCW Biologics Inc.) - SEC EDGAR Financial Statements

> HCW Biologics Inc. reported $6.70M in revenue and a net loss of $4.25M for the trailing twelve months ended September 30, 2026 (up 227.9% year over year), with a 96.6% gross margin and a -104.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/HCWB
- Markdown: https://convexityos.com/fundamentals/HCWB.md
- SEC CIK: 0001828673
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:15 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001828673&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $6.70M | +227.9% YoY |
| Operating Income | TTM | -$6.98M | -104.2% margin |
| Net Income | TTM | -$4.25M | -63.4% net margin |
| Diluted EPS | TTM | -$2.02 | Split-adjusted |
| Free Cash Flow | TTM | -$13.39M | -199.9% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $955K | Total debt: $6.83M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $54K | $2.57M | $2.84M | $6.72M | $0 | $4.10M |
| Cost of Revenue | $43K | $1.61M | $2.28M | $4.14M | $0 | -- |
| **Gross Profit** | $11K | $959K | $560K | $2.59M | $0 | -- |
| Research & Development | $5.44M | $6.39M | $7.68M | $9.34M | $8.17M | $7.26M |
| Total Operating Expenses | $13.17M | $30.42M | $26.28M | $17.67M | $13.37M | $9.92M |
| **Operating Income** | -$13.16M | -$29.46M | -$25.72M | -$15.08M | -$13.37M | -$5.82M |
| **EBITDA** | -$12.12M | -$28.27M | -$24.58M | -$14.36M | -$12.82M | -$5.25M |
| Interest Expense | $845K | $654K | $283K | $127K | $0 | -- |
| Income Before Tax | -$7.96M | -$30.02M | -$24.99M | -$14.90M | -$12.86M | -$5.80M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$7.96M | -$30.02M | -$24.99M | -$14.90M | -$12.86M | -$5.80M |
| Basic EPS | -$63.77 | -$185.72 | -$167.97 | -$100.78 | -$165.57 | -$357.53 |
| **Diluted EPS** | -$63.77 | -$185.72 | -$167.97 | -$100.78 | -$165.57 | -$357.53 |
| Basic Shares Outstanding | 349.7K | 161.7K | 149.7K | 149.3K | 78.2K | 19.8K |
| Diluted Shares Outstanding | 349.7K | 161.7K | 149.7K | 149.3K | 78.2K | 19.8K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $51K | $122K | $6.50M | $27K | $16K | $6.5K | $5.1K | $395K |
| Cost of Revenue | $27K | $229K | $11K | $22K | $12K | $5.2K | $4.1K | $316K |
| **Gross Profit** | $28K | -$94K | $6.53M | $5.4K | $3.1K | $1.3K | $1.0K | $79K |
| Research & Development | $1.24M | $1.20M | $1.26M | $1.33M | $1.40M | $1.23M | $1.48M | $1.05M |
| Total Operating Expenses | $2.62M | $3.07M | $3.30M | $4.47M | $3.30M | $3.47M | $1.97M | $3.23M |
| **Operating Income** | -$2.59M | -$3.17M | $3.24M | -$4.46M | -$3.29M | -$3.46M | -$1.97M | -$3.15M |
| **EBITDA** | -$2.47M | -$3.04M | $3.38M | -- | -$3.12M | -$3.17M | -$1.55M | -$2.46M |
| Interest Expense | $142K | $101K | $109K | $212K | $127K | $229K | $256K | $260K |
| Income Before Tax | -$3.22M | -$5.22M | $3.80M | $719K | -$4.55M | -$1.93M | -$2.20M | -- |
| Income Tax Expense | $0 | $0 | $330K | $0 | -- | -- | $0 | $0 |
| **Net Income** | -$3.22M | -$5.22M | $3.47M | $719K | -$4.55M | -$1.93M | -$2.20M | -$3.37M |
| Basic EPS | -$2.83 | -$11.58 | $2.22 | -- | -$12.09 | -$40.72 | -$11.82 | -- |
| **Diluted EPS** | -$2.83 | -$11.58 | $2.22 | -- | -$12.09 | -$40.72 | -$11.82 | -- |
| Basic Shares Outstanding | 2.1M | 1.3M | 904.5K | -- | 376.7K | 296.7K | 186.2K | -- |
| Diluted Shares Outstanding | 2.1M | 1.3M | 904.5K | -- | 376.7K | 296.7K | 186.2K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.95M | $4.67M | $3.60M | $22.33M | $11.73M | $8.46M |
| Short-Term Investments | $0 | $0 | $0 | $9.74M | $24.98M | -- |
| **Cash & Short-Term Investments** | $1.95M | $4.67M | $3.60M | $32.06M | $36.71M | $8.46M |
| Accounts Receivable, Net | $32K | $582K | $1.54M | $418K | $133K | $2.50M |
| Other Current Assets | $78K | $114K | $231K | $196K | $1.44M | $655K |
| **Total Current Assets** | $2.28M | $5.70M | $6.40M | $34.07M | $40.48M | $12.15M |
| Property, Plant & Equipment, Net | $20.88M | $22.91M | $20.45M | $10.80M | $1.12M | $1.62M |
| Long-Term Investments | $1.33M | $1.60M | $1.60M | $1.60M | $11.52M | $1.60M |
| Other Non-Current Assets | $28K | $28K | $57K | $334K | $393K | $34K |
| **Total Non-Current Assets** | $22.24M | $24.54M | $22.11M | $12.74M | $13.03M | $3.25M |
| **Total Assets** | $24.52M | $30.24M | $28.51M | $46.81M | $53.51M | $15.40M |
| Accounts Payable | $13.14M | $22.33M | $6.17M | $1.23M | $224K | $155K |
| Short-Term Debt | $6.81M | $6.31M | $119K | $38.27M | -- | -- |
| Deferred Revenue (Current) | $0 | $0 | $0 | $0 | -- | -- |
| **Total Current Liabilities** | $21.06M | $29.63M | $8.75M | $2.96M | $2.32M | $1.00M |
| Long-Term Debt | -- | -- | $6.18M | -- | $0 | -- |
| Other Non-Current Liabilities | $693K | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $693K | $7.38M | $6.30M | $6.42M | $0 | $31.12M |
| **Total Liabilities** | $21.76M | $37.01M | $15.05M | $9.38M | $2.32M | $32.12M |
| **Total Debt (incl. Leases)** | $6.81M | $6.31M | $6.33M | $38.47M | $0 | -- |
| Common Stock | $55 | $111 | $3.6K | $3.6K | $3.6K | -- |
| Retained Earnings | -$108.5M | -$100.6M | -$70.53M | -$45.54M | -$30.64M | -$16.72M |
| **Total Stockholders' Equity** | $2.76M | -$6.77M | $13.46M | $37.43M | $51.19M | -$16.72M |
| Total Equity | $2.76M | -$6.77M | $13.46M | $37.43M | $51.19M | -$16.72M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $955K | $741K | $1.23M | $1.95M | $1.10M | $2.44M | $1.11M | $4.67M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Cash & Short-Term Investments** | $955K | $741K | $1.23M | $1.95M | $1.10M | $2.44M | $1.11M | $4.67M |
| Accounts Receivable, Net | -- | $18K | $75K | $32K | $31K | $22K | $87K | $582K |
| Other Current Assets | $85K | $98K | $120K | $78K | $250K | $141K | $443K | $114K |
| **Total Current Assets** | $1.28M | $1.14M | $1.72M | $2.28M | $1.59M | $2.90M | $1.89M | $5.70M |
| Property, Plant & Equipment, Net | $18.96M | $20.75M | $20.77M | $20.88M | $22.50M | $22.64M | $22.76M | $22.91M |
| Long-Term Investments | $4.85M | $4.85M | $4.83M | $1.33M | $1.33M | $3.35M | $1.60M | $1.60M |
| Other Non-Current Assets | $28K | $28K | $28K | $28K | $28K | $28K | $28K | $28K |
| **Total Non-Current Assets** | $23.85M | $25.63M | $25.62M | $22.24M | $23.86M | $26.01M | $24.39M | $24.54M |
| **Total Assets** | $25.13M | $26.77M | $27.34M | $24.52M | $25.45M | $28.91M | $26.29M | $30.24M |
| Accounts Payable | $9.44M | $10.61M | $11.79M | $13.14M | $18.97M | $19.35M | $19.73M | $22.33M |
| Short-Term Debt | $6.83M | $6.56M | $6.58M | $6.81M | $6.81M | $6.42M | $6.23M | $6.31M |
| Deferred Revenue (Current) | $297K | $348K | $470K | $0 | -- | -- | -- | $0 |
| **Total Current Liabilities** | $17.61M | $18.65M | $19.96M | $21.06M | $26.86M | $26.85M | $27.14M | $29.63M |
| Other Non-Current Liabilities | -- | -- | $693K | $693K | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $693K | $693K | $1.62M | $693K | $693K | $2.12M | $7.71M | $7.38M |
| **Total Liabilities** | $18.30M | $19.34M | $21.58M | $21.76M | $27.55M | $28.96M | $34.85M | $37.01M |
| **Total Debt (incl. Leases)** | $6.83M | $6.56M | $6.58M | $6.81M | $6.81M | $6.42M | $6.23M | $6.31M |
| Common Stock | $223 | $161 | $673 | $55 | $262 | $215 | $4.5K | $111 |
| Retained Earnings | -$113.5M | -$110.3M | -$105.0M | -$108.5M | -$109.2M | -$104.7M | -$102.8M | -$100.6M |
| **Total Stockholders' Equity** | $6.82M | $7.43M | $5.76M | $2.76M | -$2.11M | -$52K | -$8.56M | -$6.77M |
| Total Equity | $6.82M | $7.43M | $5.76M | $2.76M | -$2.11M | -$52K | -$8.56M | -$6.77M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$7.96M | -$30.02M | -$24.99M | -$14.90M | -$12.86M | -$5.80M |
| Depreciation & Amortization | $1.04M | $1.18M | $1.14M | $718K | $544K | $573K |
| Stock-Based Compensation | $769K | $1.01M | $1.00M | $1.12M | $361K | $22K |
| Change in Receivables | $550K | $954K | -$1.12M | -$285K | $2.37M | -$2.50M |
| **Operating Cash Flow** | -$13.39M | -$14.23M | -$22.51M | -$10.39M | -$10.98M | -$10.43M |
| Capital Expenditure | $0 | -$262K | -$6.20M | -$10.28M | -$47K | -$187K |
| **Free Cash Flow** | -$13.39M | -$14.49M | -$28.72M | -$20.66M | -$11.02M | -$10.62M |
| **Investing Cash Flow** | $0 | -$262K | $3.80M | $14.71M | -$35.02M | -$187K |
| Common Stock Issued | $5.49M | $6.46M | $24K | $16K | $30K | $9.9K |
| **Financing Cash Flow** | $10.67M | $15.57M | -$15K | $6.27M | $49.27M | $11.72M |
| **Net Change in Cash** | -$2.72M | $1.08M | -$18.73M | $10.60M | $3.27M | $1.10M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.22M | -$5.22M | $3.47M | $719K | -$4.55M | -$1.93M | -$2.20M | -$3.37M |
| Depreciation & Amortization | $120K | $127K | $142K | -- | $174K | $292K | $419K | $683K |
| Stock-Based Compensation | $364 | $1.2K | $10K | $9.2K | $205K | $278K | $276K | $292K |
| Change in Receivables | $18K | $56K | -$43K | -$1.5K | -$9.1K | $66K | $495K | $70K |
| **Operating Cash Flow** | -$2.62M | -$3.97M | -$1.58M | -$3.36M | -$3.24M | -$3.28M | -$3.51M | -$2.83M |
| Capital Expenditure | -- | -- | -- | $0 | $0 | $0 | $0 | -$113K |
| **Free Cash Flow** | -- | -- | -- | -$3.36M | -$3.24M | -$3.28M | -$3.51M | -$2.95M |
| **Investing Cash Flow** | -- | -- | -- | $0 | $0 | $0 | $0 | -$113K |
| Common Stock Issued | -- | -- | -- | $4.02M | $0 | $1.47M | $1.7K | $3.96M |
| **Financing Cash Flow** | $2.83M | $3.48M | $852K | $4.21M | $1.90M | $4.61M | -$53K | $6.62M |
| **Net Change in Cash** | $214K | -$488K | -$724K | $856K | -$1.34M | $1.33M | -$3.57M | $3.68M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 20.0% | 37.4% | 19.7% | 38.5% | -- | -- |
| **Operating Margin** | -24270.7% | -1147.6% | -905.0% | -224.3% | -- | -142.1% |
| **Net Profit Margin** | -14677.1% | -1169.7% | -879.5% | -221.7% | -- | -141.5% |
| Return on Equity (ROE) | -287.9% | -- | -185.7% | -39.8% | -25.1% | -- |
| Return on Assets (ROA) | -32.5% | -99.3% | -87.7% | -31.8% | -24.0% | -37.7% |
| Current Ratio | 0.11x | 0.19x | 0.73x | 11.52x | 17.44x | 12.14x |
| Quick Ratio | 0.09x | 0.18x | 0.59x | 10.99x | 15.87x | 10.94x |
| Debt to Equity | 2.46x | -- | 0.47x | 1.03x | 0.00x | -- |
| **Revenue Growth (YoY)** | -97.9% | -9.7% | -57.7% | -- | -100.0% | -- |
| Gross Profit Growth (YoY) | -98.9% | +71.2% | -78.3% | -- | -- | -- |
| 5Y Revenue / Share Growth | -99.9% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 96.6% | 96.7% | 99.9% | 20.0% | 20.0% | 20.0% | 23.9% | 37.4% |
| **Operating Margin** | -104.2% | -115.3% | -121.9% | -24310.5% | -2812.5% | -1472.3% | -1656.2% | -1147.8% |
| **Net Profit Margin** | -63.4% | -83.8% | -35.0% | -14677.4% | -2855.8% | -1368.8% | -1712.8% | -1169.7% |
| Return on Equity (ROE) | -62.3% | -75.2% | -39.7% | -287.9% | -- | -- | -- | -- |
| Return on Assets (ROA) | -16.9% | -20.9% | -8.4% | -32.5% | -47.4% | -39.4% | -94.2% | -99.3% |
| Current Ratio | 0.07x | 0.06x | 0.09x | 0.11x | 0.06x | 0.11x | 0.07x | 0.19x |
| Quick Ratio | 0.05x | 0.04x | 0.07x | 0.09x | 0.04x | 0.09x | 0.04x | 0.18x |
| Debt to Equity | 1.00x | 0.88x | 1.14x | 2.46x | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | +227.9% | +1758.5% | +128231.7% | -93.2% | -96.3% | -98.9% | -99.6% | -70.2% |
| Gross Profit Growth (YoY) | +800.9% | -7266.9% | +644710.5% | -93.2% | -96.3% | -99.3% | -99.8% | -68.7% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
